Your browser doesn't support javascript.
loading
StarGazer: A Hybrid Intelligence Platform for Drug Target Prioritization and Digital Drug Repositioning Using Streamlit.
Lee, Chiyun; Lin, Junxia; Prokop, Andrzej; Gopalakrishnan, Vancheswaran; Hanna, Richard N; Papa, Eliseo; Freeman, Adrian; Patel, Saleha; Yu, Wen; Huhn, Monika; Sheikh, Abdul-Saboor; Tan, Keith; Sellman, Bret R; Cohen, Taylor; Mangion, Jonathan; Khan, Faisal M; Gusev, Yuriy; Shameer, Khader.
Afiliação
  • Lee C; Data Science and Artificial Intelligence, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
  • Lin J; Georgetown University, Washington, DC, United States.
  • Prokop A; Biometrics, Oncology R&D, AstraZeneca, Warsaw, Poland.
  • Gopalakrishnan V; Discovery Microbiome, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States.
  • Hanna RN; Early Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States.
  • Papa E; Research Data and Analytics, R&D IT, AstraZeneca, Cambridge, United Kingdom.
  • Freeman A; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
  • Patel S; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
  • Yu W; Data Science and Artificial Intelligence, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States.
  • Huhn M; Biometrics and Information Sciences, BioPharmaceuticals R&D, AstraZeneca, Mölndal, Sweden.
  • Sheikh AS; Data Science and Artificial Intelligence, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
  • Tan K; Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
  • Sellman BR; Discovery Microbiome, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States.
  • Cohen T; Discovery Microbiome, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States.
  • Mangion J; Data Science and Artificial Intelligence, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
  • Khan FM; Data Science and Artificial Intelligence, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States.
  • Gusev Y; Georgetown University, Washington, DC, United States.
  • Shameer K; Data Science and Artificial Intelligence, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States.
Front Genet ; 13: 868015, 2022.
Article em En | MEDLINE | ID: mdl-35711912
Target prioritization is essential for drug discovery and repositioning. Applying computational methods to analyze and process multi-omics data to find new drug targets is a practical approach for achieving this. Despite an increasing number of methods for generating datasets such as genomics, phenomics, and proteomics, attempts to integrate and mine such datasets remain limited in scope. Developing hybrid intelligence solutions that combine human intelligence in the scientific domain and disease biology with the ability to mine multiple databases simultaneously may help augment drug target discovery and identify novel drug-indication associations. We believe that integrating different data sources using a singular numerical scoring system in a hybrid intelligent framework could help to bridge these different omics layers and facilitate rapid drug target prioritization for studies in drug discovery, development or repositioning. Herein, we describe our prototype of the StarGazer pipeline which combines multi-source, multi-omics data with a novel target prioritization scoring system in an interactive Python-based Streamlit dashboard. StarGazer displays target prioritization scores for genes associated with 1844 phenotypic traits, and is available via https://github.com/AstraZeneca/StarGazer.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido